Navigation Links
NBTY to Webcast Presentation at B. Riley & Co. Annual Las Vegas Institutional Investor Conference; Announces Preliminary Unaudited Net Sales Results for February 2009
Date:3/10/2009

RONKONKOMA, N.Y., March 10 /PRNewswire-FirstCall/ -- NBTY, Inc. (NYSE: NTY) (www.NBTY.com), a leading global manufacturer and marketer of nutritional supplements, today announced that it will webcast the presentation by Harvey Kamil, President and Chief Financial Officer of NBTY, at the B. Riley & Co. Annual Las Vegas Institutional Investor Conference on Wednesday, March 18, 2009.

The presentation is scheduled to be webcast live on the Company Web site, www.nbty.com, on Wednesday, March 18, 2009 at 1:00PM Pacific Time (4:00PM Eastern Time).

NBTY's preliminary unaudited net sales results for February 2009 by segment are as follows:

                                    NET SALES
                            (Preliminary and Unaudited)
                             FOR THE MONTH OF FEBRUARY
                                  ($In Millions)

                                             2009     2008   % Change
                                             ----     ----   --------

    Wholesale / US Nutrition                 $111      $81      38%

    North American Retail                     $17      $17       1%

    European Retail                           $42      $51     -18%

    Direct Response / E-Commerce              $17      $19     -10%

    Total                                    $187     $168      12%
                                             ====     ====      ===

Wholesale / US Nutrition net sales for the month of February 2009 include $33 million from Leiner which was acquired in July 2008. Without Leiner sales, the Wholesale / US Nutrition net sales would have decreased 3% for the one-month period. North American Retail same store sales increased 2% for the one month period. European Retail net sales for February 2009 include $7 million from Julian Graves, which NBTY acquired in September 2008. Excluding Julian Graves sales, European Retail net sales decreased 8% in local currency (British Pound Sterling), and 32% in US dollars for the period.

NBTY's preliminary unaudited net sales results for the two months January and February 2009 by segment are as follows:

                                    NET SALES
                            (Preliminary and Unaudited)
                    FOR THE TWO MONTHS OF JANUARY AND FEBRUARY
                                  ($In Millions)

                                             2009     2008   % Change
                                             ----     ----   --------

    Wholesale / US Nutrition                 $220     $164      34%

    North American Retail                     $34      $34       1%

    European Retail                           $88     $107     -18%

    Direct Response / E-Commerce              $38      $40      -6%

    Total                                    $380     $346      10%
                                             ====     ====      ===


Wholesale / US Nutrition net sales for the two-month period of January and February 2009 include $59 million from Leiner which was acquired in July 2008. Without Leiner sales, the Wholesale / US Nutrition net sales would have decreased 2% for the two-month period. North American Retail same store sales increased 2% for the two-month period. European Retail net sales for the two-month period of January and February 2009 include $15 million from Julian Graves, which NBTY acquired in September 2008. Excluding Julian Graves sales, European Retail net sales decreased 8% in local currency (British Pound Sterling), and 32% in US dollars for the two-month period.

ABOUT NBTY

NBTY is a leading global vertically integrated manufacturer, marketer and distributor of a broad line of high-quality, value-priced nutritional supplements in the United States and throughout the world. Under a number of NBTY and third party brands, the Company offers over 22,000 products, including products marketed by the Company's Nature's Bounty(R) (www.NaturesBounty.com), Vitamin World(R) (www.VitaminWorld.com), Puritan's Pride(R) (www.Puritan.com), Holland & Barrett(R) (www.HollandAndBarrett.com), Rexall(R) (www.Rexall.com), Sundown(R) (www.SundownNutrition.com), MET-Rx(R) (www.MetRX.com), Worldwide Sport Nutrition(R) (www.SportNutrition.com), American Health(R) (www.AmericanHealthUS.com), GNC (UK)(R) (www.GNC.co.uk), DeTuinen(R) (www.DeTuinen.nl), LeNaturiste(TM) (www.LeNaturiste.com), SISU(R) (www.SISU.com), Solgar(R) (www.Solgar.com), Good 'n' Natural(R) (www.goodnnatural.com), Home Health(TM) (www.homehealthus.com), Julian Graves, and Ester-C(R) (www.Ester-C.com) brands. NBTY routinely posts information that may be important to investors on its web site.

    Contact:  Harvey Kamil                            Carl Hymans
    NBTY, Inc.                                        G.S. Schwartz & Co.
    President & Chief Financial Officer               212-725-4500
    631-200-2020                                      carlh@schwartz.com

'/>"/>
SOURCE NBTY, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Alexzas Corporate Presentation to be Webcast at the Cowen & Company 29th Annual Health Care Conference
2. Medivation Announces Fourth Quarter and Year-End 2008 Teleconference and Webcast on March 16, 2009
3. Arena Pharmaceuticals to Report Fourth Quarter and Full Year 2008 Financial Results and to Host Conference Call and Webcast on Thursday, March 12, 2009
4. Clarient Reschedules Fourth Quarter and Year-End 2008 Financial Results Release To Wednesday, March 11th; Conference Call and Webcast Rescheduled For 5:00 PM EDT That Day
5. Thoratec Presentation at Raymond James Conference to Be Webcast
6. DiagnoCure to Host Q1 2009 Earnings Conference Call and Webcast
7. Sunrise to Host Conference Call and Webcast to Discuss Fourth-Quarter and Full-Year 2008 Financial Results
8. Volcano Corporation Announces Webcast of February 25th Analyst Day
9. Telik Announces Year-End Financial Release, Conference Call and Webcast
10. Webcast Alert: Usinas Siderurgicas de Minas Gerais S.A. - USIMINAS Announces Fourth Quarter 2008 Earnings Results Webcast
11. Webcast Alert: Genomma Lab Announces Fourth Quarter 2008 Earnings Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... 2017 , ... ProRehab Physical Therapy (PRPT) is ... therapy provider for Derby City CrossFit, effective immediately. , In addition to treating ... effectively as possible, ProRehab’s sports physical therapists will work with athletes to maximize ...
(Date:4/25/2017)... ... 2017 , ... A recent report from the Wisconsin Institute ... 2015-16 school year across Wisconsin’s public schools, charter schools, and private schools participating ... student test score performance, the report’s limited analyses fail to provide answers as ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... they rely on contracted partners to help with process innovation in drug formulation ... drug formulation experience along with state-of-the-art analytical equipment in support of their development ...
(Date:4/25/2017)... ... 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest quality of ... I focus on preventative care with all my patients to alleviate possible future issues. I ... free to contact my office and my trained staff will assist you in any way ...
(Date:4/25/2017)... ... 25, 2017 , ... Vetoquinol USA® , a world-class ... part of the EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in ... immunologic level. , The scientifically-developed Flexadin UCII supports the body’s normal repair of ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... April 24, 2017 Solentim, the developer ... the addition of a major new product line ... Seeding,). The VIPS has been developed for automatically ... microplates as part of the process to generate ... simple and more reliable solution when compared to ...
(Date:4/20/2017)... Texas , April 20, 2017  Vivify Health, ... mobile devices, has been awarded a very significant patent ... via EMRs to continual care via digital health.  This ... key intellectual property and further secures Vivify,s position as ... launched in 2009, was the first company to apply ...
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
Breaking Medicine Technology: